Bhubaneswar: Odisha Chief Minister Naveen Patnaik has congratulated Bharat Biotech as the World Health Organisation (WHO) granted Emergency Use Listing approval to India’s indigenously-developed Covid vaccine.
Congratulate @BharatBiotech as the Technical Advisory Group of @WHO has recommended the emergency use of ‘#Covaxin’ vaccine across the world. Commend the stellar efforts of our scientists and researchers to have given the vaccine to the world and help save precious lives.
— Naveen Patnaik (@Naveen_Odisha) November 3, 2021
The global health group’s Technical Advisory Group (TAG) issued the final decision.
The WHO, in a tweet, said: “WHO has granted emergency use listing (EUL) to Covaxin, developed by Bharat Biotech, adding to a growing portfolio of vaccines validated by WHO for the prevention of Covid 19”.
The TAG last met on October 27 and had agreed upon to conduct the final risk assessment after receiving additional data from the manufacturer. Bharat Biotech was expected to submit the additional data by this weekend.
Covaxin, which was co-developed by Hyderabad-based Bharat Biotech, in collaboration with the government’s Indian Council of Medical Research (ICMR), was granted emergency authorisation in the country in January.
It has demonstrated 77.8 per cent effectiveness against symptomatic Covid-19 and 65.2 per cent protection against the new Delta variant. Bharat Biotech said that it concluded the final analysis of Covaxin efficacy from Phase 3 trials.